ABS course Map
-
list
Together with the UK Breast Cancer Group, the Association of Breast Pathology and the British Society of Breast Radiology, the ABS have produced a guidance document for Neoadjuvant Chemotherapy (NAC)....
Association of Breast Pathology, ABS, British Society of Breast Radiology & UK Breast Cancer Group, UK | United Kingdom
23.01.2023 | Added: 23.01.2023
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
listGuideline list -
desktop_windows
Radiotherapy and oncoplastic surgery
Mr Ashutosh Kothari | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Radiotherapy Oncoplastic Surgery
desktop_windowsWebcast desktop_windows -
desktop_windows
Revision surgery post radiotherapy (1)
Professor J Michael Dixon OBE | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Radiotherapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Scar therapy, pre and after radiotherapy
Mrs Emma Holly | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Radiotherapy Scars
desktop_windowsWebcast desktop_windows -
desktop_windows
Primum Non Nocere: Abemaciclib
Dr Daniel Ahari | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Targeted therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
CDK4 and other advances in hormone positive cancers
Professor Richard Simcock | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
PARP inhibitors in breast surgery
Mr Tim Crook | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Targeted therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Professor Stuart McIntosh | ABS Conference 2024
13.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy Trials
desktop_windowsWebcast desktop_windows -
desktop_windows
Improving selection of NAC for young breast cancer patients - study proposal
Ashrafun Nessa | ABS Conference 2024
13.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy Management of the Younger Patient
desktop_windowsWebcast desktop_windows -
desktop_windows
The impact of BMI on response to NACT in breast cancer
Richa Jaiswil | ABS Conference 2024
13.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy
desktop_windowsWebcast desktop_windows -
list
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer
In May 2024, NICE published a partial review of previous guidance on tumour profiling tests for guiding adjuvant chemotherapy decisions in early breast cancer. The pre-existing guidance made recommend...
NICE | United Kingdom
01.05.2024 | Added: 01.08.2024
Classifications: Adjuvant & Neoadjuvant Treatment
listGuideline list -
desktop_windows
ENGAGE study: Breast Cancer Chemoprevention
Dr Samuel Smith | ABS Multidisciplinary Meeting 2019
14.01.2024 | Added: 14.01.2019
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Chemoprevention Trials
desktop_windowsWebcast desktop_windows -
desktop_windows
Upfront Oncotype DX in early breast cancer management
Dr Raouef Ahmed Bichoo | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Early Breast Cancer Gene Expression Profiling
desktop_windowsWebcast desktop_windows -
desktop_windows
The value of progesterone receptor expression in predicting PCR following NACT
Miss Emily King | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Surgery after neo-adjuvant chemotherapy why are breast conservation rates not higher?
Dr Hiram S. Cody III | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
menu_book
MonarchE is an open-label, randomised, phase 3 trial which recruited high risk hormone receptor positive, HER2 receptor negative, node-positive breast cancer patients (n=5637). Patients were randomise...
Prof Stephen R D Johnston, MD et al | The Lancet Oncology
06.12.2022 | Added: 06.12.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Adjuvant treatment Endocrine therapy Trials
menu_bookPublication menu_book -
menu_book
This prospective multicentre cohort study aimed to determine surgical decision-making in the breast and axilla, as well as pathological complete response (pCR) rate in patients undergoing neoadjuvant ...
Hiba Fatayer et al | British Journal of Surgery
09.09.2022 | Added: 09.09.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Early Breast Cancer Trials
menu_bookPublication menu_book -
desktop_windows
Introduction to the ABS, BSBR & UKBCG Guidance on Neoadjuvant Chemotherapy
n/a | Webinar
06.09.2022 | Added: 06.09.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows